| Mrs Julie Louise Minning, MA, CCC-SLP | |
|
251 Landis Ave Ste 201, Chula Vista, CA 91910-2629 | |
| (619) 498-8450 | |
| (619) 498-8453 |
| Full Name | Mrs Julie Louise Minning |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 251 Landis Ave Ste 201, Chula Vista, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043432230 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 10096 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Julie Louise Minning, MA, CCC-SLP 538 Crystal Downs Gln, Escondido, CA 92026-1490 Ph: (619) 743-9080 | Mrs Julie Louise Minning, MA, CCC-SLP 251 Landis Ave Ste 201, Chula Vista, CA 91910-2629 Ph: (619) 498-8450 |
News Archive
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
A Japanese research group has successfully grafted human iPS cell-derived inner ear cells that express human-derived proteins into the inner ears of embryonic mice.
AutoGenomics, a leader in providing automated, molecular microarray testing solutions, announced today that they have received their first Health Canada Medical Device Class III approvals for their automated INFINITI Pharmacogenomic (PGx) testing system.
Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid binds to killer T cells, it acts almost like an "invisibility cloak," preventing T cells from recognizing and attacking nascent tumors.
› Verified 3 days ago
Alex Batista, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2060 Otay Lakes Rd Ste 270, Chula Vista, CA 91913 Phone: 619-546-0039 Fax: 619-546-0037 | |
Elizabeth Martinez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2060 Otay Lakes Rd # 270, Chula Vista, CA 91913 Phone: 619-546-0039 | |
Roxanna Palma, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 333 H St Ste 6010, Chula Vista, CA 91910 Phone: 619-600-1395 | |
Wrela Johnston, MS-CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2827 Sutter Ridge Dr, Chula Vista, CA 91914 Phone: 724-816-6322 | |
Lynn Severin, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2521 Windward Way, Chula Vista, CA 91914 Phone: 858-405-4172 | |
Kristin Rottino, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2521 Windward Way, Chula Vista, CA 91914 Phone: 619-546-0039 |